Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections
Produced in the U.S., the generic anti-fungal drug is fully substitutable for Noxafil
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Jan 24
Produced in the U.S., the generic anti-fungal drug is fully substitutable for Noxafil
29 Jan 24
The AI-powered tool uses advanced multimodal behavioural signal processing and ML to collect mental health symptoms and offer…
29 Jan 24
Pfizer and Astellas Pharma seek approval for Padcev with Keytruda as the first-line treatment of adult patients with…
29 Jan 24
The CheckMate -67T trial showed that the subcutaneous nivolumab demonstrated noninferior pharmacokinetics and objective response rate compared to…
29 Jan 24
Rain Stockholders to Receive $1.16 Per Share in Cash Plus Contingent Value Rights
29 Jan 24
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month
24 Jan 24
Microsoft's General Manager of Global Health and Life Sciences Elena Bonfiglioli, left, and Dr. Jong-yoon Chun, CEO and…
23 Jan 24
The acquisition is expected to strengthen Sandoz’s ophthalmology portfolio in the US and includes the BLA, product inventory,…
23 Jan 24
IMC-2 is a combination of valacyclovir and celecoxib and its Phase 2 programme is expected to start in…
23 Jan 24
The MHRA conducted a thorough review into the effectiveness of current measures to reduce the risk of potentially…